Evofem Biosciences

About:

Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.

Website: https://www.evofem.com

Twitter/X: Evofem

Top Investors: Invesco, Aditxt Therapeutics, Morgan Stanley, Alta Partners, Stifel Financial

Description:

Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.

Total Funding Amount:

$472M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)evofem.com

Founders:

Saundra Pelletier

Number of Employees:

51-100

Last Funding Date:

2024-05-15

IPO Status:

Public

© 2025 bioDAO.ai